Index
RUT
Market Cap
713.98M
Enterprise Value
844.63M
Income
4.80M
Sales
249.72M
Book/sh
33.73
Cash/sh
5.49
Employees
717
IPO
Feb 29, 1984
P/E
150.96
Forward P/E
11.72
PEG
-
P/S
2.86
P/B
3.78
P/C
23.26
P/FCF
13.50
EV/EBITDA
18.59
EV/Sales
3.38
Quick Ratio
1.32
Current Ratio
1.79
Debt/Eq
0.85
LT Debt/Eq
0.81
Option/Short
No / Yes
EPS (ttm)
0.85
EPS next Y
10.88
EPS next Q
2.29
EPS this Y
-10.69%
EPS next Y
6.82%
EPS next 5Y
-
EPS past 3/5Y
90.85% 13.55%
Sales past 3/5Y
4.38% 13.22%
EPS Y/Y TTM
842.96%
Sales Y/Y TTM
3.04%
EPS Q/Q
-42.44%
Sales Q/Q
1.00%
Insider Own
4.24%
Insider Trans
-3.02%
Inst Own
94.24%
Inst Trans
6.38%
ROA
1.12%
ROE
2.66%
ROIC
1.40%
Gross Margin
57.35%
Oper. Margin
9.00%
Profit Margin
1.92%
SMA20
-1.75%
SMA50
1.23%
SMA200
24.35%
Trades
Shs Outstand
5.60M
Shs Float
5.36M
52W High
144.35 -11.61%
52W Low
69.51 83.56%
Volatility
3.64% 3.81%
ATR (14)
4.83
RSI (14)
50.38
Beta
1.08
Rel Volume
0.98
Avg Volume
133.24K
Volume
43,090
Perf Week
1.13%
Perf Month
-5.23%
Perf Quarter
26.39%
Perf Half Y
25.98%
Perf YTD
62.54%
Perf Year
61.67%
Perf 3Y
32.14%
Perf 5Y
-57.89%
Perf 10Y
5.01%
Prev Close
125.16
Price
127.59
Change %
1.94%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-07-25 Upgrade
Wells Fargo
Underweight → Equal Weight
$67
Aug-28-24 Initiated
Wells Fargo
Underweight
$120
Jan-04-24 Upgrade
Evercore ISI
In-line → Outperform
$100 → $125
Jan-04-21 Downgrade
Evercore ISI
Outperform → In-line
$300
Nov-10-20 Initiated
KeyBanc Capital Markets
Sector Weight
$287
Oct-02-20 Initiated
JP Morgan
Neutral
$260
Dec-04-19 Initiated
Jefferies
Buy
Aug-26-19 Initiated
Evercore ISI
Outperform
$250
Jun-10-16 Downgrade
Sidoti
Buy → Neutral
Oct-13-26 08:00AM
Oct-09-26 04:00PM
Aug-11-26 08:30AM
01:04AM
Aug-10-26 04:17PM
04:01PM
Loading…
04:01PM
Aug-03-26 08:00AM
Jul-06-26 09:50AM
Jun-17-26 04:42AM
May-27-26 08:18AM
(Associated Press)
-14.48%
08:00AM
May-05-26 01:39PM
Apr-02-26 06:00PM
Mar-09-26 04:30PM
Feb-20-26 07:02AM
08:11AM
Loading…
Feb-03-26 08:11AM
(Associated Press Finance)
+8.73%
08:00AM
Jan-07-26 05:00PM
Dec-18-25 07:00PM
Dec-03-25 05:35PM
Nov-25-25 08:09AM
Nov-12-25 03:14PM
Nov-06-25 07:01PM
(Associated Press Finance)
04:15PM
Oct-03-25 11:46AM
11:01AM
Sep-22-25 06:53AM
Sep-05-25 06:34PM
Aug-18-25 02:01PM
Aug-05-25 09:15AM
08:10AM
Loading…
08:10AM
(Associated Press Finance)
08:00AM
Jul-31-25 05:45PM
Jul-03-25 12:00PM
Jul-02-25 03:20PM
May-28-25 09:15AM
08:23AM
(Associated Press Finance)
08:00AM
May-15-25 05:25PM
May-14-25 05:45PM
May-13-25 05:35PM
May-08-25 08:45AM
Apr-07-25 03:00PM
Apr-03-25 03:51PM
Mar-26-25 12:00PM
Feb-13-25 08:31AM
Feb-11-25 12:20PM
Feb-04-25 09:15AM
08:17AM
(Associated Press Finance)
08:00AM
Jan-17-25 01:15PM
Jan-06-25 03:00PM
Nov-07-24 09:20AM
08:27AM
(Associated Press Finance)
08:00AM
Oct-15-24 05:02PM
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
(Associated Press Finance)
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
(Associated Press Finance)
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
(Associated Press Finance)
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
(Associated Press Finance)
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Owens Gary M Former Officer Aug 27 '26 Proposed Sale 127.75 20,358 2,600,734 Aug 27 03:33 PM Owens Gary M Former Officer Aug 21 '26 Proposed Sale 122.50 20,000 2,450,059 Aug 21 03:53 PM Capone Mark Christopher Director Aug 15 '26 Option Exercise 0.00 2,784 0 6,213 Aug 17 07:40 PM Alltoft Jennifer Sadie Director Aug 15 '26 Option Exercise 0.00 2,784 0 7,662 Aug 17 07:32 PM Ladiwala Shiraz Shabanali Director Aug 15 '26 Option Exercise 0.00 3,810 0 12,333 Aug 17 05:55 PM Hall Shannon Director Aug 15 '26 Option Exercise 0.00 2,784 0 6,973 Aug 17 05:46 PM Tripeny R Tony Director Aug 15 '26 Option Exercise 0.00 2,784 0 9,082 Aug 17 05:30 PM Sullivan John James Director Aug 15 '26 Option Exercise 0.00 2,784 0 20,618 Aug 17 05:01 PM Sullivan John James Director Aug 13 '26 Sale 112.80 7,093 800,090 17,834 Aug 17 12:18 PM Kadia Siddhartha President and CEO Aug 13 '26 Buy 112.80 7,093 800,090 7,093 Aug 17 11:49 AM Tripeny R Tony Director Aug 13 '26 Buy 113.69 900 102,321 6,298 Aug 17 11:27 AM Crennen Lyndsey Elizabeth CAO Jun 18 '26 Option Exercise 95.10 726 69,043 2,199 Jun 23 01:34 PM Crennen Lyndsey Elizabeth CAO Jun 22 '26 Sale 89.50 442 39,560 2,020 Jun 23 01:34 PM Archbold Brian David SVP Operations Jun 18 '26 Option Exercise 95.10 3,324 316,112 7,034 Jun 23 01:02 PM Archbold Brian David SVP Operations Jun 22 '26 Sale 89.50 2,516 225,187 6,377 Jun 23 01:02 PM Sakys John CFO Jun 18 '26 Option Exercise 95.10 3,792 360,619 20,330 Jun 23 12:23 PM Sakys John CFO Jun 22 '26 Sale 89.50 2,827 253,022 19,785 Jun 23 12:23 PM Sakys John Officer Jun 22 '26 Proposed Sale 89.50 2,827 253,022 Jun 22 03:56 PM Archbold Brian David Officer Jun 22 '26 Proposed Sale 89.50 2,516 225,187 Jun 22 03:51 PM Archbold Brian David SVP Operations Jun 16 '26 Sale 101.27 1,151 116,558 3,710 Jun 17 12:23 PM Crennen Lyndsey Elizabeth CAO Jun 16 '26 Sale 101.27 118 11,950 1,473 Jun 17 12:19 PM Sakys John CFO Jun 16 '26 Sale 101.27 1,223 123,850 16,538 Jun 17 12:09 PM Archbold Brian David Officer Jun 16 '26 Proposed Sale 101.27 1,151 116,558 Jun 16 03:33 PM Sakys John Officer Jun 16 '26 Proposed Sale 101.27 1,223 123,850 Jun 16 03:31 PM Owens Gary M Former Officer Jun 16 '26 Proposed Sale 101.27 3,706 375,296 Jun 16 03:29 PM Archbold Brian David SVP Operations Jun 15 '26 Option Exercise 104.08 2,454 255,412 4,861 Jun 16 02:44 PM Sakys John CFO Jun 15 '26 Option Exercise 104.08 2,717 282,785 17,761 Jun 16 02:15 PM Ladiwala Shiraz Shabanali Director Mar 10 '26 Buy 72.23 3,500 252,805 8,523 Mar 10 05:43 PM Capone Mark Christopher Director Mar 10 '26 Buy 76.35 1,301 99,331 3,429 Mar 10 03:46 PM Tripeny R Tony Director Mar 10 '26 Buy 76.00 1,315 99,940 5,398 Mar 10 03:39 PM Owens Gary M President and CEO Oct 27 '25 Option Exercise 0.00 11,558 0 64,135 Oct 28 03:08 PM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
VP & CFO Mr. John V. Sakys CPA
Senior Vice President of Operations & Continuous Improvement Mr. Brian David Archbold
M.S. Dr. Siddhartha Chandrakant Kadia B.E.
Chief Accounting Officer Ms. Lyndsey Crennen